{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiaajsy33v2flpxsskargprv2yhzcpaier4vlmrblui54xhbotj7da",
    "uri": "at://did:plc:7ltlvigjik37fxbx2bat4p22/app.bsky.feed.post/3mmatohi6xd22"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiahqwh5fcbk6bxlfyceanluezf46idgxjscrpe2mghcld6aqtlo4i"
    },
    "mimeType": "image/jpeg",
    "size": 67433
  },
  "path": "/disease/obesity/weight-loss-drugs-adults-asthma/",
  "publishedAt": "2026-05-20T00:09:29.000Z",
  "site": "https://refractor.io",
  "tags": [
    "Continue Reading",
    "Obesity",
    "Illnesses and conditions",
    "Body and Mind",
    "GLP-1 receptor agonists",
    "Weight Loss",
    "Inflammation",
    "Asthma",
    "Asthma inhaler",
    "Respiratory health",
    "Lung",
    "Chronic illness"
  ],
  "textContent": "Could glucagon-like peptide-1 receptor agonists (GLP-1 RAs) nix the inflammation that drives asthma? Maybe, according to a large national study in Denmark.\n\nContinue Reading\n\n**Category:** Obesity, Illnesses and conditions, Body and Mind\n\n**Tags:** GLP-1 receptor agonists, Weight Loss, Inflammation, Asthma, Asthma inhaler, Respiratory health, Lung, Chronic illness",
  "title": "Weight-loss drugs present new hope for adults with asthma"
}